Relief Therapeutics Holding AG (RLFTF)

[thesisthink]

We are invested in Relief, not NeuroRX.

Relief
(partnership agreement by population)

US/Canada
184,500,000

Isreal
4,500,000

Europe
597,600,000

Asia
3,680,000,000

South America
344,800,000

Australia
20,000,000

Africa
1,120,000,000

Total Population favoring Relief Therapeutics
5,951,400,000
divided by
world population 7,572,000,000 =
.78 % of all revenue (world)
This math is skewed, since it will only play out if they're is a equal amount of treatments in each country, and will tilt in favor of NeuroRX if MORE treatments end up in countries where partnerships are 50/50, vs 80/20.

Also, I don't know the restrictions RLF-100 has in other countries other than US, EUR, CANADA.

imo - please disregard if numbers are off.